Drug profile · INN
lifitegrast
XIIDRA
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
lifitegrast (XIIDRA) is an FDA-listed pharmaceutical active ingredient. Route of administration: ophthalmic. Current US regulatory status: approved.
Key facts
INN lifitegrast
Brand XIIDRA
Route OPHTHALMIC
Formulation SOLUTION/DROPS
ATC code S01XA25
Frequently asked questions
What is lifitegrast?
lifitegrast (XIIDRA) is an FDA-listed pharmaceutical active ingredient. Route of administration: ophthalmic. Current US regulatory status: approved.
What is the brand name for lifitegrast?
XIIDRA is a marketed brand name for lifitegrast. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of lifitegrast?
lifitegrast has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.